Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00547742 · ClinicalTrials.gov registry record

Correlation of PET-CT Studies With Serum Protein Analysis

A clinical trial, sponsored by Stanford University.

Completed
Registry status
1,500
Enrollment target

NCT00547742: Completed study, sponsored by Stanford University.

NCT00547742 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 1,500 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00547742 has completed, sponsored by Stanford University.

COMPLETED
Registry status
1,500 participants
Enrollment target

Study Summary

To correlate serum proteomics patterns with PET/CT findings to improve cancer diagnosis, staging, prognosis, and therapy monitoring.

Interventions

  • PROCEDURE phlebotomy
  • PROCEDURE PET/CT Scan

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2005-07
Est. Completion 2009-06
Stanford University

1,744 total trials

What the finished NCT00547742 record still lists

NCT00547742 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 2 interventions - of which phlebotomy is the first listed.

NCT00547742 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00547742 about?

NCT00547742 is a clinical study titled "Correlation of PET-CT Studies With Serum Protein Analysis". To correlate serum proteomics patterns with PET/CT findings to improve cancer diagnosis, staging, prognosis, and therapy monitoring.

What is the current status of trial NCT00547742?

This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2005-07. Estimated completion is 2009-06.

What interventions are being tested in trial NCT00547742?

The interventions under investigation include: phlebotomy (PROCEDURE), PET/CT Scan (PROCEDURE).

Who is sponsoring clinical trial NCT00547742?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00547742, the US trial registry maintained by the National Library of Medicine. NCT00547742 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.